Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-24-045983
Filing Date
2024-11-07
Accepted
2024-11-07 07:20:12
Documents
4
Effectiveness Date
2024-11-07

Document Format Files

Seq Description Document Type Size
1 S-8 avtx-formsx82024inducement.htm S-8 79153
2 EX-FILING FEES ex-107sx8filingfeetable202.htm EX-FILING FEES 23662
3 EX-5.1 ex-51sx8wyrickopinionconse.htm EX-5.1 7891
4 EX-23.1 ex-231sx8eyconsent2024indu.htm EX-23.1 2240
  Complete submission text file 0001628280-24-045983.txt   114092
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Filer) CIK: 0001534120 (see all company filings)

EIN.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-283048 | Film No.: 241433166
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)